MDMA therapy for PTSD inpatients
Part of Mental health clinical trials.
This trial tests whether high-dose MDMA, given during intensive inpatient therapy, can help people with PTSD that hasn't improved with other treatments. It takes place at a specialized trauma center and involves several therapy sessions with the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must have been diagnosed with PTSD that hasn't gotten better with other treatments
- You must be a current patient at ARQ Centre'45 and speak Dutch
- You must have a support person who can be contacted if needed
- You must be able to swallow pills and have a body weight of at least 48 kg (about 106 pounds)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether psilocybin (a psychedelic substance) combined with psychotherapy can help veterans with PTSD who haven't improved with standard treatments. The treatment involves a few sessions where you take psilocybin under supervision.
This study tests whether MDMA, when combined with therapy, can help young adults with post-traumatic stress disorder (PTSD) that started after childhood trauma. The goal is to see if this treatment can reduce PTSD symptoms and improve well-being.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
This trial tests if MDMA (a drug that can help with therapy) along with talk therapy can help military members with PTSD. It is designed for active duty, National Guard, or Reserve service members who have had PTSD for at least six months.
This trial tests whether MDMA (the drug in ecstasy) combined with a type of talk therapy called massed exposure therapy can help treat PTSD. It may be an option if standard treatments haven't worked well enough.
This Phase 2 study tests whether MDMA combined with therapy that uses exposure (gradual confronting of trauma memories) can reduce PTSD symptoms. It may help people who meet PTSD criteria, can follow strict safety rules, and can complete medicine-session monitoring.
Hear when a new Posttraumatic Stress Disorder (PTSD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.